Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-08

Clinical Trial Update: tDCS to Enhance Cognitive Training in Schizophrenia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trials evaluate whether transcranial direct current stimulation (tDCS) can enhance cognitive training in schizophrenia; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tDCS (transcranial direct current stimulation) (transcranial direct current stimulation)

Snippet

Sponsor: The University of New South Wales | Conditions: Schizophrenia | Phase 1, Phase 2 | Status: COMPLETED